Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Feldman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Development and characterization of the high-purity factor IX, ReplenineP A Feldman
Vox Sanguinis|January 1, 1994
Sensitivity of the fibrinogen clotting time: an in vitro test of potential thrombogenicityP A Feldman, S McGrath, H Evans
Developments in Biological Standardization|January 1, 1987
Interim results of surveillance for NANBH in patients receiving heated concentrates produced in EnglandJ K Smith, L Winkelman, P A Feldman
Current Studies in Hematology and Blood Transfusion|January 1, 1989
Severe heat treatment of lyophilised coagulation factorsL Winkelman, P A Feldman, D R Evans
The Journal of Membrane Biology|February 1, 1997
Loss of gap junction plaques and inhibition of intercellular communication in ilimaquinone-treated BICR-M1Rk and NRK cellsP A Feldman, J Kim, D W Laird
Nature|March 21, 1970
Physical sciences: short-term periodic variations following an optical flare of Sco X-1J R Gribbin, P A Feldman, S H Plagemann
Vox Sanguinis|January 1, 1994
Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatographyP L Roberts, C P Walker, P A Feldman
Biochemical and Biophysical Research Communications|February 15, 1988
The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesisD C Eustice, P A Feldman, A M Slee
Nature|May 2, 1970
On the nature of the underlying star associated with Sco X-lP A Feldman, J R Gribbin, S H Plagemann
Antimicrobial Agents and Chemotherapy|August 1, 1988
Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisD C Eustice, P A Feldman, I Zajac, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Development and characterization of the high-purity factor IX, ReplenineP A Feldman
Vox Sanguinis|January 1, 1994
Sensitivity of the fibrinogen clotting time: an in vitro test of potential thrombogenicityP A Feldman, S McGrath, H Evans
Developments in Biological Standardization|January 1, 1987
Interim results of surveillance for NANBH in patients receiving heated concentrates produced in EnglandJ K Smith, L Winkelman, P A Feldman
Current Studies in Hematology and Blood Transfusion|January 1, 1989
Severe heat treatment of lyophilised coagulation factorsL Winkelman, P A Feldman, D R Evans
The Journal of Membrane Biology|February 1, 1997
Loss of gap junction plaques and inhibition of intercellular communication in ilimaquinone-treated BICR-M1Rk and NRK cellsP A Feldman, J Kim, D W Laird
Nature|March 21, 1970
Physical sciences: short-term periodic variations following an optical flare of Sco X-1J R Gribbin, P A Feldman, S H Plagemann
Vox Sanguinis|January 1, 1994
Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatographyP L Roberts, C P Walker, P A Feldman
Biochemical and Biophysical Research Communications|February 15, 1988
The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesisD C Eustice, P A Feldman, A M Slee
Nature|May 2, 1970
On the nature of the underlying star associated with Sco X-lP A Feldman, J R Gribbin, S H Plagemann
Antimicrobial Agents and Chemotherapy|August 1, 1988
Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisD C Eustice, P A Feldman, I Zajac, et al.
Pageof 2